Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v8-FR
Language French French
Date Updated 2018-01-22 2018-01-22
Drug Identification Number 01959034 01959034
Brand name ACT-HIB ACT-HIB
Common or Proper name Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate) Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN
Strength(s) 10 μG 30 μG 10 μG 30 μG
Dosage form(s) Powder For Solution Powder For Solution
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials / 5 fioles de 0,5 mL 5 x 0.5 mL vials / 5 fioles de 0,5 mL
ATC code J07AG J07AG
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-03-28 2017-03-28
Actual start date 2017-03-28 2017-03-28
Estimated end date 2017-11-15 2017-11-15
Actual end date 2018-01-18 2018-01-18
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Act-Hib lot# UI880AA was released to the market on January 18, 2018. The shortage has been resolved on January 18, 2018.
Health Canada comments